WallStreetZenWallStreetZen

NASDAQ: PYPD
Polypid Ltd Stock Ownership - Who owns Polypid?

Insider buying vs selling

Have Polypid Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PYPD insiders and whales buy or sell their stock.

PYPD Shareholders

What type of owners hold Polypid Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Boothbay Fund Management LLC0.62%122,898$51.62kInstitution
Raymond James Financial Services Advisors Inc0.21%42,286$17.76kInstitution
Morgan Stanley0.19%36,806$15.46kInstitution
Advisor Group Holdings Inc0.14%27,750$11.66kInstitution
Millennium Management LLC0.13%25,943$10.90kInstitution
Cerity Partners LLC0.09%18,709$7.86kInstitution
Geode Capital Management LLC0.06%12,545$5.27kInstitution
Ubs Group Ag0.05%9,806$4.12kInstitution
Steward Partners Investment Advisory LLC0.00%200$84.00Institution
Royal Bank Of Canada0.00%77$32.34Institution

1 of 2

PYPD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PYPD1.50%0.00%
CWBR0.50%99.50%Net Buying
AGLE63.19%16.13%Net Buying
PTIX2.20%3.49%
ENVB10.98%10.86%

Polypid Stock Ownership FAQ

Who owns Polypid?

Polypid (NASDAQ: PYPD) is owned by 1.50% institutional shareholders, 0.00% Polypid insiders, and 98.50% retail investors. Boothbay Fund Management LLC is the largest individual Polypid shareholder, owning 122,898.00 shares representing 0.62% of the company. Boothbay Fund Management LLC's Polypid shares are currently valued at $51.62k.

If you're new to stock investing, here's how to buy Polypid stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.